Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mehra Golshan, M.D.

Title
Institution
Department
Address
Phone
Fax

Biography
MIT Sloan School of Management, CambridgeMBA05/2019Business
Case Western Reserve University, Cleveland OHMD05/1996Medicine

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Hwang ES, Balch CM, Balch GC, Feldman SM, Golshan M, Grobmyer SR, Libutti SK, Margenthaler JA, Sasidhar M, Turaga KK, Wong SL, McMasters KM, Tanabe KK. Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change. Ann Surg Oncol. 2020 Jun 14. PMID: 32535870.
    Citations:    
  2. Golshan M, Loibl S, Wong SM, Houber JB, O'Shaughnessy J, Rugo HS, Wolmark N, McKee MD, Maag D, Sullivan DM, Metzger-Filho O, Von Minckwitz G, Geyer CE, Sikov WM, Untch M. Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial. JAMA Surg. 2020 Jan 08; e195410. PMID: 31913413.
    Citations:    
  3. Golshan M, Wong SM, Loibl S, Huober JB, O'Shaughnessy J, Rugo HS, Wolmark N, Ansell P, Maag D, Sullivan DM, Metzger-Filho O, Von Minckwitz G, Geyer CE, Sikov WM, Untch M. Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial. Eur J Surg Oncol. 2020 Feb; 46(2):223-228. PMID: 31606288.
    Citations:    
  4. Weiss A, Wong S, Golshan M, Freedman RA, Metzger O, Bellon J, Mittendorf EA, King TA. Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach. Ann Surg Oncol. 2019 Dec; 26(13):4326-4336. PMID: 31562601.
    Citations:    
  5. Aydogan T, Sezgin E, Ilvan S, Yilmaz OC, Aslan N, Golshan M, Aydogan F. Comparison of Radio-guided Occult Lesion Localization (ROLL) and Magnetic Occult Lesion Localization (MOLL) for Non-palpable Lesions: A Phantom Model Study. Clin Breast Cancer. 2020 Feb; 20(1):e9-e13. PMID: 31699672.
    Citations:    
  6. Mallory MA, Valero MG, Hu J, Barry WT, Losk K, Nimbkar S, Golshan M. Bilateral mastectomy operations and the role for the cosurgeon technique: A Nationwide analysis of surgical practice patterns. Breast J. 2020 02; 26(2):220-226. PMID: 31498509.
    Citations:    
  7. Warren LEG, Chen YH, Halasz LM, Brock JE, Capuco A, Punglia RS, Wong JS, Golshan M, Bellon JR. Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ. Breast Cancer Res Treat. 2019 Dec; 178(3):607-615. PMID: 31493031.
    Citations:    
  8. Özkurt E, Golshan M. ASO Author Reflections: De-escalation of Breast Cancer Surgery-A Leap Forward. Ann Surg Oncol. 2019 12; 26(Suppl 3):711-712. PMID: 31468219.
    Citations:    
  9. Özkurt E, Sakai T, Wong SM, Tukenmez M, Golshan M. Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option? Ann Surg Oncol. 2019 Oct; 26(10):3260-3268. PMID: 31342356.
    Citations:    
  10. Wong SM, Chun YS, Sagara Y, Golshan M, Erdmann-Sager J. National Patterns of Breast Reconstruction and Nipple-Sparing Mastectomy for Breast Cancer, 2005-2015. Ann Surg Oncol. 2019 Oct; 26(10):3194-3203. PMID: 31342383.
    Citations:    
  11. Wong SM, Weiss A, Mittendorf EA, King TA, Golshan M. Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis. Ann Surg Oncol. 2019 Oct; 26(11):3517-3525. PMID: 31342389.
    Citations:    
  12. Sakai T, Ozkurt E, DeSantis S, Wong SM, Rosenbaum L, Zheng H, Golshan M. National trends of synchronous bilateral breast cancer incidence in the United States. Breast Cancer Res Treat. 2019 Nov; 178(1):161-167. PMID: 31325072.
    Citations:    
  13. Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K, Shen AH, DeSantis S, Dominici L, Golshan M, Weiss A, Bellon J, Mittendorf EA, King TA. Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3502-3509. PMID: 31228134.
    Citations:    
  14. Ligibel JA, Dillon D, Giobbie-Hurder A, McTiernan A, Frank E, Cornwell M, Pun M, Campbell N, Dowling RJO, Chang MC, Tolaney S, Chagpar AB, Yung RL, Freedman RA, Dominici LS, Golshan M, Rhei E, Taneja K, Huang Y, Brown M, Winer EP, Jeselsohn R, Irwin ML. Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study. Clin Cancer Res. 2019 Sep 01; 25(17):5398-5406. PMID: 31018921.
    Citations:    
  15. Cole AP, Krasnova A, Ramaswamy A, Fletcher SA, Friedlander DF, McNabb-Baltar J, Melnitchouk N, Lipsitz SR, Sun M, Kibel AS, Golshan M, Haider AH, Weissman JS, Trinh QD. Recommended Cancer Screening in Accountable Care Organizations: Trends in Colonoscopy and Mammography in the Medicare Shared Savings Program. J Oncol Pract. 2019 06; 15(6):e547-e559. PMID: 30998420.
    Citations:    
  16. Heshmati K, Harris DA, Rosner B, Pranckevicius E, Ardestani A, Cho N, Golshan M, Ng WT, Ligibel J, Tavakkoli A, Sheu E. Association of Bariatric Surgery Status with Reduced HER2+ Breast Cancers: a Retrospective Cohort Study. Obes Surg. 2019 04; 29(4):1092-1098. PMID: 30659466.
    Citations:    Fields:    
  17. Zinboonyahgoon N, Vlassakov K, Lirk P, Spivey T, King T, Dominici L, Golshan M, Strichartz G, Edwards R, Schreiber K. Benefit of regional anaesthesia on postoperative pain following mastectomy: the influence of catastrophising. Br J Anaesth. 2019 08; 123(2):e293-e302. PMID: 31331591.
    Citations:    
  18. Cole AP, Nguyen DD, Meirkhanov A, Golshan M, Melnitchouk N, Lipsitz SR, Kilbridge KL, Kibel AS, Cooper Z, Weissman J, Trinh QD. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States. JAMA Netw Open. 2019 02 01; 2(2):e187633. PMID: 30707230.
    Citations:    
  19. Punglia RS, Bifolck K, Golshan M, Lehman C, Collins L, Polyak K, Mittendorf E, Garber J, Hwang SE, Schnitt SJ, Partridge AH, King TA. Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). JNCI Cancer Spectr. 2018 Nov; 2(4):pky063. PMID: 30627695.
    Citations:    
  20. Whorms DS, Giess CS, Golshan M, Freedman RA, Bunnell CA, Alper EC, Losk K, Khorasani R. Clinical Impact of Second Opinion Radiology Consultation for Patients With Breast Cancer. J Am Coll Radiol. 2019 Jun; 16(6):814-823. PMID: 30579707.
    Citations:    Fields:    
  21. Choi J, Laws A, Hu J, Barry W, Golshan M, King T. Correction to: Margins in Breast-Conserving Surgery After Neoadjuvant Therapy. Ann Surg Oncol. 2018 12; 25(Suppl 3):995. PMID: 30145646.
    Citations:    Fields:    
  22. Schreiber KL, Zinboonyahgoon N, Xu X, Spivey T, King T, Dominici L, Partridge A, Golshan M, Strichartz G, Edwards RR. Preoperative Psychosocial and Psychophysical Phenotypes as Predictors of Acute Pain Outcomes After Breast Surgery. J Pain. 2019 05; 20(5):540-556. PMID: 30476655.
    Citations:    Fields:    
  23. Laws A, Anderson K, Hu J, McLean K, Novak L, Dominici LS, Nakhlis F, Carty M, Caterson S, Chun Y, Duggan M, Barry W, Connell N, Golshan M, King TA. Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy. Ann Surg Oncol. 2018 Nov; 25(12):3548-3555. PMID: 30128903.
    Citations:    Fields:    
  24. Choi J, Laws A, Hu J, Barry W, Golshan M, King T. Margins in Breast-Conserving Surgery After Neoadjuvant Therapy. Ann Surg Oncol. 2018 Nov; 25(12):3541-3547. PMID: 30128902.
    Citations:    Fields:    
  25. Natsuhara KH, Losk K, King TA, Lin NU, Camuso K, Golshan M, Pochebit S, Brock JE, Bunnell CA, Freedman RA. Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria. Oncologist. 2019 05; 24(5):595-602. PMID: 30076279.
    Citations:    Fields:    
  26. Barbie TU, Golshan M. De Novo Stage 4 Metastatic Breast Cancer: A Surgical Disease? Ann Surg Oncol. 2018 Oct; 25(11):3109-3111. PMID: 30019303.
    Citations:    Fields:    Translation:Humans
  27. Spivey TL, Gutowski ED, Zinboonyahgoon N, King TA, Dominici L, Edwards RR, Golshan M, Schreiber KL. Chronic Pain After Breast Surgery: A Prospective, Observational Study. Ann Surg Oncol. 2018 Oct; 25(10):2917-2924. PMID: 30014456.
    Citations:    Fields:    Translation:Humans
  28. Wong SM, Golshan M. Management of In-Breast Tumor Recurrence. Ann Surg Oncol. 2018 Oct; 25(10):2846-2851. PMID: 29947005.
    Citations:    Fields:    Translation:Humans
  29. Grossmith S, Nguyen A, Hu J, Plichta JK, Nakhlis F, Cutone L, Dominici L, Golshan M, Duggan M, Carter K, Rhei E, Barbie T, Calvillo K, Nimbkar S, Bellon J, Wong J, Punglia R, Barry W, King TA. Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series. Ann Surg Oncol. 2018 Nov; 25(12):3527-3534. PMID: 29868979.
    Citations:    Fields:    
  30. Valero MG, Mallory MA, Losk K, Tukenmez M, Hwang J, Camuso K, Bunnell C, King T, Golshan M. Surgeon Variability and Factors Predicting for Reoperation Following Breast-Conserving Surgery. Ann Surg Oncol. 2018 Sep; 25(9):2573-2578. PMID: 29786129.
    Citations:    Fields:    
  31. Criscitiello C, Golshan M, Barry WT, Viale G, Wong S, Santangelo M, Curigliano G. Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis. Eur J Cancer. 2018 07; 97:1-6. PMID: 29734046.
    Citations: 1     Fields:    Translation:Humans
  32. Mallory MA, Tarabanis C, Schneider E, Nimbkar S, Golshan M. Bilateral mastectomies: can a co-surgeon technique offer improvements over the single-surgeon method? Breast Cancer Res Treat. 2018 Aug; 170(3):641-646. PMID: 29687179.
    Citations:    Fields:    
  33. Loibl S, O'Shaughnessy J, Untch M, Sikov WM, Rugo HS, McKee MD, Huober J, Golshan M, von Minckwitz G, Maag D, Sullivan D, Wolmark N, McIntyre K, Ponce Lorenzo JJ, Metzger Filho O, Rastogi P, Symmans WF, Liu X, Geyer CE. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. Lancet Oncol. 2018 04; 19(4):497-509. PMID: 29501363.
    Citations: 8     Fields:    
  34. Valero MG, Golshan M. Management of the Axilla in Early Breast Cancer. Cancer Treat Res. 2018; 173:39-52. PMID: 29349757.
    Citations:    Fields:    Translation:Humans
  35. Losk K, Freedman RA, Lin NU, Golshan M, Pochebit SM, Lester SC, Natsuhara K, Camuso K, King TA, Bunnell CA. Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation. J Oncol Pract. 2017 09; 13(9):e815-e820. PMID: 28858535.
    Citations:    Fields:    Translation:Humans
  36. Sagara Y, Julia W, Golshan M, Toi M. Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast. Front Oncol. 2017; 7:192. PMID: 28894698.
    Citations: 2     
  37. Sagara Y, Freedman RA, Wong SM, Aydogan F, Nguyen A, Barry WT, Golshan M. Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013. Breast Cancer Res Treat. 2017 Nov; 166(2):583-592. PMID: 28776282.
    Citations: 1     Fields:    Translation:Humans
  38. Nakhlis F, Lester S, Denison C, Wong SM, Mongiu A, Golshan M. Complex sclerosing lesions and radial sclerosing lesions on core needle biopsy: Low risk of carcinoma on excision in cases with clinical and imaging concordance. Breast J. 2018 03; 24(2):133-138. PMID: 28685897.
    Citations: 1     Fields:    
  39. Benedetti DJ, Golshan M, Kesselheim JC. Going the Distance: Ethical Issues Arising When Patients Seek Cancer Care From International Settings. J Glob Oncol. 2018 09; 4:1-4. PMID: 30241217.
    Citations: 1     Fields:    
  40. Nakhlis F, Regan MM, Warren LE, Bellon JR, Hirshfield-Bartek J, Duggan MM, Dominici LS, Golshan M, Jacene HA, Yeh ED, Mullaney EE, Overmoyer B. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. 2017 Sep; 24(9):2563-2569. PMID: 28560598.
    Citations:    Fields:    Translation:Humans
  41. Wong SM, King T, Boileau JF, Barry WT, Golshan M. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ. Ann Surg Oncol. 2017 Sep; 24(9):2509-2517. PMID: 28455673.
    Citations: 2     Fields:    Translation:Humans
  42. Mallory MA, Sagara Y, Aydogan F, DeSantis S, Jayender J, Caragacianu D, Gombos E, Vosburgh KG, Jolesz FA, Golshan M. Feasibility of Intraoperative Breast MRI and the Role of Prone Versus Supine Positioning in Surgical Planning for Breast-Conserving Surgery. Breast J. 2017 Nov; 23(6):713-717. PMID: 28295903.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  43. Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer. Ann Surg. 2017 03; 265(3):581-589. PMID: 28169929.
    Citations: 24     Fields:    Translation:Humans
  44. Wong SM, Stout NK, Punglia RS, Prakash I, Sagara Y, Golshan M. Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis. Cancer. 2017 Jul 15; 123(14):2609-2617. PMID: 28221673.
    Citations:    Fields:    Translation:Humans
  45. Ollila DW, Cirrincione CT, Berry DA, Carey LA, Sikov WM, Hudis CA, Winer EP, Golshan M. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative). J Am Coll Surg. 2017 Apr; 224(4):688-694. PMID: 28089784.
    Citations:    Fields:    Translation:Humans
  46. Losk K, Vaz-Luis I, Camuso K, Batista R, Lloyd M, Tukenmez M, Golshan M, Lin NU, Bunnell CA. Factors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer Center. J Natl Compr Canc Netw. 2016 12; 14(12):1519-1526. PMID: 27956536.
    Citations:    Fields:    Translation:Humans
  47. Criscitiello C, Curigliano G, Burstein HJ, Wong S, Esposito A, Viale G, Giuliano M, Veronesi U, Santangelo M, Golshan M. Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity? Eur J Surg Oncol. 2016 Dec; 42(12):1780-1786. PMID: 27825710.
    Citations: 1     Fields:    Translation:Humans
  48. Barroso-Sousa R, Paes FR, Vaz-Luis I, Batista RB, Costa RB, Losk K, Camuso K, Metzger-Filho O, Hughes ME, Bunnell CA, Golshan M, Winer EP, Lin NU. Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective study. Breast. 2016 Dec; 30:136-140. PMID: 27721193.
    Citations:    Fields:    Translation:Humans
  49. Golshan M, Cirrincione CT, Sikov WM, Carey LA, Berry DA, Overmoyer B, Henry NL, Somlo G, Port E, Burstein HJ, Hudis C, Winer E, Ollila DW. Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance). Breast Cancer Res Treat. 2016 11; 160(2):297-304. PMID: 27704226.
    Citations: 3     Fields:    Translation:Humans
  50. Sagara Y, Freedman RA, Mallory MA, Wong SM, Barry WT, Golshan M. Reply to K. Lin et al. J Clin Oncol. 2016 10 01; 34(28):3485-6. PMID: 27458285.
    Citations:    Fields:    
  51. Gombos EC, Jayender J, Richman DM, Caragacianu DL, Mallory MA, Jolesz FA, Golshan M. Intraoperative Supine Breast MR Imaging to Quantify Tumor Deformation and Detection of Residual Breast Cancer: Preliminary Results. Radiology. 2016 Dec; 281(3):720-729. PMID: 27332738.
    Citations: 3     Fields:    Translation:Humans
  52. Ollila DW, Golshan M, Boughey JC. How successful is NST in increasing breast-conserving surgery rates in TNBC patients? Bull Am Coll Surg. 2016 Apr; 101(4):40-2. PMID: 27337767.
    Citations:    Fields:    Translation:Humans
  53. Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer. Ann Surg. 2016 Mar 08. PMID: 26967636.
    Citations: 7     Fields:    
  54. Golshan M, Losk K, Mallory MA, Camuso K, Cutone L, Caterson S, Bunnell CA. Implementation of a Breast/Reconstruction Surgery Coordinator to Reduce Preoperative Delays for Patients Undergoing Mastectomy With Immediate Reconstruction. J Oncol Pract. 2016 Mar; 12(3):e338-43. PMID: 26883406.
    Citations: 1     Fields:    Translation:Humans
  55. Sagara Y, Freedman RA, Vaz-Luis I, Mallory MA, Wong SM, Aydogan F, DeSantis S, Barry WT, Golshan M. Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study. J Clin Oncol. 2016 Apr 10; 34(11):1190-6. PMID: 26834064.
    Citations: 13     Fields:    Translation:Humans
  56. Nakhlis F, Ahmadiyeh N, Lester S, Raza S, Lotfi P, Golshan M. Erratum to: Papilloma on Core Biopsy: Excision vs. Observation. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1602. PMID: 25448802.
    Citations:    Fields:    
  57. Nakhlis F, Gilmore L, Gelman R, Bedrosian I, Ludwig K, Hwang ES, Willey S, Hudis C, Iglehart JD, Lawler E, Ryabin NY, Golshan M, Schnitt SJ, King TA. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020). Ann Surg Oncol. 2016 Mar; 23(3):722-8. PMID: 26542585.
    Citations: 3     Fields:    Translation:Humans
  58. Tolaney SM, Boucher Y, Duda DG, Martin JD, Seano G, Ancukiewicz M, Barry WT, Goel S, Lahdenrata J, Isakoff SJ, Yeh ED, Jain SR, Golshan M, Brock J, Snuderl M, Winer EP, Krop IE, Jain RK. Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients. Proc Natl Acad Sci U S A. 2015 Nov 17; 112(46):14325-30. PMID: 26578779.
    Citations: 35     Fields:    Translation:HumansCTClinical Trials
  59. Mallory MA, Losk K, Camuso K, Caterson S, Nimbkar S, Golshan M. Does "Two is Better Than One" Apply to Surgeons? Comparing Single-Surgeon Versus Co-surgeon Bilateral Mastectomies. Ann Surg Oncol. 2016 Apr; 23(4):1111-6. PMID: 26514122.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  60. Sagara Y, Mallory MA, Tukenmez M, Golshan M. Tumor subtype and race in male breast cancer: A population-based cohort study. J Clin Oncol. 2015 Oct; 33(28_suppl):149. PMID: 28147751.
    Citations:    
  61. Mallory MA, Losk K, Camuso K, Golshan M. Does "two is better than one" apply to surgeons? Comparing single-surgeon and cosurgeon bilateral mastectomy outcomes. J Clin Oncol. 2015 Oct; 33(28_suppl):35. PMID: 28147776.
    Citations:    
  62. Wong SM, Freedman RA, Sagara Y, Stamell EF, Desantis SD, Barry WT, Golshan M. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma. Cancer. 2015 Dec 15; 121(24):4333-40. PMID: 26376021.
    Citations: 3     Fields:    Translation:Humans
  63. Golshan M, Cirrincione CT, Sikov WM, Berry DA, Jasinski S, Weisberg TF, Somlo G, Hudis C, Winer E, Ollila DW. Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance). Ann Surg. 2015 Sep; 262(3):434-9; discussion 438-9. PMID: 26222764.
    Citations: 20     Fields:    Translation:HumansCTClinical Trials
  64. Golshan M, Losk K, Mallory MA, Camuso K, Troyan S, Lin NU, Kadish S, Bunnell CA. Variation in Additional Breast Imaging Orders and Impact on Surgical Wait Times at a Comprehensive Cancer Center. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S428-34. PMID: 26307233.
    Citations: 1     Fields:    Translation:Humans
  65. Aydogan F, Mallory MA, Tukenmez M, Sagara Y, Ozturk E, Ince Y, Celik V, Akca T, Golshan M. A low cost training phantom model for radio-guided localization techniques in occult breast lesions. J Surg Oncol. 2015 Sep; 112(4):449-51. PMID: 26250621.
    Citations:    Fields:    Translation:HumansAnimals
  66. Sagara Y, Mallory MA, Wong S, Aydogan F, DeSantis S, Barry WT, Golshan M. Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study. JAMA Surg. 2015 Aug; 150(8):739-45. PMID: 26039049.
    Citations: 12     Fields:    Translation:Humans
  67. Criscitiello C, Giuliano M, Curigliano G, De Laurentiis M, Arpino G, Carlomagno N, De Placido S, Golshan M, Santangelo M. Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do? Eur J Surg Oncol. 2015 Oct; 41(10):1288-92. PMID: 26238477.
    Citations: 5     Fields:    Translation:Humans
  68. Mallory MA, Losk K, Lin NU, Sagara Y, Birdwell RL, Cutone L, Camuso K, Bunnell C, Aydogan F, Golshan M. The Influence of Radiology Image Consultation in the Surgical Management of Breast Cancer Patients. Ann Surg Oncol. 2015 Oct; 22(10):3383-8. PMID: 26202551.
    Citations: 3     Fields:    Translation:Humans
  69. Bellon JR, Golshan M, Solin LJ. Controversies in Radiation Oncology for Early-Stage Breast Cancer. Ann Surg Oncol. 2015 Oct; 22(10):3213-8. PMID: 26202560.
    Citations:    Fields:    Translation:Humans
  70. Wong SM, Freedman RA, Stamell E, Sagara Y, Brock JE, Desantis SD, Golshan M. Modern Trends in the Surgical Management of Paget's Disease. Ann Surg Oncol. 2015 Oct; 22(10):3308-16. PMID: 26202552.
    Citations: 1     Fields:    Translation:Humans
  71. Liao GS, Chou YC, Golshan M, Hsu HM, Hong ZJ, Yu JC, Zhu JH. Prognostic value of the lymph node ratio in breast cancer subtypes. Am J Surg. 2015 Oct; 210(4):749-54. PMID: 26130268.
    Citations: 6     Fields:    Translation:Humans
  72. Rosenberg SM, Sepucha K, Ruddy KJ, Tamimi RM, Gelber S, Meyer ME, Schapira L, Come SE, Borges VF, Golshan M, Winer EP, Partridge AH. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer. Ann Surg Oncol. 2015 Nov; 22(12):3809-15. PMID: 25930247.
    Citations: 15     Fields:    Translation:Humans
  73. Mallory MA, Chikarmane SA, Raza S, Lester S, Caterson SA, Golshan M. Bilateral synchronous benign phyllodes tumors. Am Surg. 2015 May; 81(5):E192-4. PMID: 25975306.
    Citations:    Fields:    Translation:Humans
  74. Sagara Y, Barry WT, Mallory MA, Vaz-Luis I, Aydogan F, Brock JE, Winer EP, Golshan M, Metzger-Filho O. Surgical Options and Locoregional Recurrence in Patients Diagnosed with Invasive Lobular Carcinoma of the Breast. Ann Surg Oncol. 2015 Dec; 22(13):4280-6. PMID: 25893416.
    Citations: 2     Fields:    Translation:Humans
  75. Son BH, Dominici LS, Aydogan F, Shulman LN, Ahn SH, Cho JY, Coopey SB, Kim SB, Min HE, Valero M, Wang J, Caragacianu D, Gong GY, Hevelone ND, Baek S, Golshan M. Young women with breast cancer in the United States and South Korea: comparison of demographics, pathology and management. Asian Pac J Cancer Prev. 2015; 16(6):2531-5. PMID: 25824792.
    Citations: 2     Fields:    Translation:Humans
  76. Nakhlis F, Ahmadiyeh N, Lester S, Raza S, Lotfi P, Golshan M. Papilloma on core biopsy: excision vs. observation. Ann Surg Oncol. 2015 May; 22(5):1479-82. PMID: 25361885.
    Citations: 5     Fields:    Translation:Humans
  77. Golshan M, Sagara Y, Wexelman B, Aydogan F, Desantis S, Elise Min H, Vosburgh K, Jagadeesan J, Caragacianu D, Gombos E, Jolesz FA. Pilot study to evaluate feasibility of image-guided breast-conserving therapy in the advanced multimodal image-guided operating (AMIGO) suite. Ann Surg Oncol. 2014 Oct; 21(10):3356-7. PMID: 25047476.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  78. Golshan M, Losk K, Kadish S, Lin NU, Hirshfield-Bartek J, Cutone L, Sagara Y, Aydogan F, Camuso K, Weingart SN, Bunnell C. Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center. Breast Cancer Res Treat. 2014 Nov; 148(1):125-33. PMID: 25270121.
    Citations: 3     Fields:    Translation:Humans
  79. Calligaris D, Caragacianu D, Liu X, Norton I, Thompson CJ, Richardson AL, Golshan M, Easterling ML, Santagata S, Dillon DA, Jolesz FA, Agar NY. Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis. Proc Natl Acad Sci U S A. 2014 Oct 21; 111(42):15184-9. PMID: 25246570.
    Citations: 28     Fields:    Translation:Humans
  80. Sikov WM, Berry DA, Perou CM, Singh B, Cirrincione CT, Tolaney SM, Kuzma CS, Pluard TJ, Somlo G, Port ER, Golshan M, Bellon JR, Collyar D, Hahn OM, Carey LA, Hudis CA, Winer EP. Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance). J Clin Oncol. 2015 Jan 01; 33(1):13-21. PMID: 25092775.
    Citations: 116     Fields:    Translation:HumansCTClinical Trials
  81. McGuire KP, Hwang ES, Cantor A, Golshan M, Meric-Bernstam F, Horton JK, Nanda R, Amos KD, Forero A, Hudis CA, Meszoely I, De Los Santos JF. Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017. Ann Surg Oncol. 2015 Jan; 22(1):75-81. PMID: 25059792.
    Citations: 4     Fields:    Translation:Humans
  82. Giess CS, Golshan M, Flaherty K, Birdwell RL. Clinical experience with aspiration of breast abscesses based on size and etiology at an academic medical center. J Clin Ultrasound. 2014 Nov-Dec; 42(9):513-21. PMID: 24975466.
    Citations: 1     Fields:    Translation:Humans
  83. Bunnell CA, Losk K, Kadish S, Lin N, Hirshfield-Bartek J, Cutone L, Camuso K, Golshan M, Weingart S. Measuring opportunities to improve timeliness of breast cancer care at Dana-Farber/Brigham and Women's Cancer Center. J Natl Compr Canc Netw. 2014 Feb; 12 Suppl 1:S5-9. PMID: 24614053.
    Citations: 1     Fields:    Translation:Humans
  84. Tolaney SM, Jeong J, Guo H, Brock J, Morganstern D, Come SE, Golshan M, Bellon J, Winer EP, Krop IE. A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer. Cancer Med. 2014 Apr; 3(2):293-9. PMID: 24464780.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  85. Kadish S, Golshan M, Lin N, Hirshfield-Bartek J, Cutone L, Bunnell CA, Weingart S. Reducing breast cancer chemotherapy treatment delays by improving the transition from surgical to medical oncology. J Clin Oncol. 2013 Nov; 31(31_suppl):51. PMID: 28136334.
    Citations:    
  86. Kansal KJ, Dominici LS, Tolaney SM, Isakoff SJ, Smith BL, Jiang W, Brock JE, Winer EP, Krop IE, Golshan M. Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction. Breast Cancer Res Treat. 2013 Sep; 141(2):255-9. PMID: 24026859.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  87. Russo AL, Arvold ND, Niemierko A, Wong N, Wong JS, Bellon JR, Punglia RS, Golshan M, Troyan SL, Brock JE, Harris JR. Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat. 2013 Jul; 140(2):353-61. PMID: 23836011.
    Citations: 11     Fields:    Translation:Humans
  88. Camp MS, Valero MG, Opara N, Benabou K, Cutone L, Caragacianu D, Dominici L, Golshan M. Intraoperative digital specimen mammography: a significant improvement in operative efficiency. Am J Surg. 2013 Oct; 206(4):526-9. PMID: 23806823.
    Citations: 1     Fields:    Translation:Humans
  89. De Los Santos JF, Cantor A, Amos KD, Forero A, Golshan M, Horton JK, Hudis CA, Hylton NM, McGuire K, Meric-Bernstam F, Meszoely IM, Nanda R, Hwang ES. Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017. Cancer. 2013 May 15; 119(10):1776-83. PMID: 23436342.
    Citations: 30     Fields:    Translation:Humans
  90. Sanders MA, Dominici L, Denison C, Golshan M, Wiecorek T, Lester SC. Paget disease of the breast with invasion from nipple skin into the dermis: an unusual type of skin invasion not associated with an adverse outcome. Arch Pathol Lab Med. 2013 Jan; 137(1):72-6. PMID: 23276177.
    Citations: 1     Fields:    Translation:Humans
  91. Toi M, Benson JR, Winer EP, Forbes JF, von Minckwitz G, Golshan M, Robertson JF, Sasano H, Cole BF, Chow LW, Pegram MD, Han W, Huang CS, Ikeda T, Kanao S, Lee ES, Noguchi S, Ohno S, Partridge AH, Rouzier R, Tozaki M, Sugie T, Yamauchi A, Inamoto T. Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference. Breast Cancer Res Treat. 2012 Dec; 136(3):919-26. PMID: 23143284.
    Citations: 2     Fields:    Translation:Humans
  92. Childs SK, Chen YH, Duggan MM, Golshan M, Pochebit S, Punglia RS, Wong JS, Bellon JR. Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):948-52. PMID: 22975615.
    Citations: 8     Fields:    Translation:Humans
  93. Margalit DN, Sreedhara M, Chen YH, Catalano PJ, Nguyen PL, Golshan M, Overmoyer BA, Harris JR, Brock JE. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy. Ann Surg Oncol. 2013 Mar; 20(3):811-8. PMID: 22956068.
    Citations: 5     Fields:    Translation:Humans
  94. Dominici L, Liao GS, Brock J, Iglehart JD, Lotfi P, Meyer J, Pandalai P, Golshan M. Large needle core biopsy of atypical ductal hyperplasia: results of surgical excision. Breast J. 2012 Sep; 18(5):506-8. PMID: 22897750.
    Citations: 2     Fields:    Translation:Humans
  95. Childs SK, Chen YH, Duggan MM, Golshan M, Pochebit S, Wong JS, Bellon JR. Surgical margins and the risk of local-regional recurrence after mastectomy without radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1133-8. PMID: 22543200.
    Citations: 1     Fields:    Translation:Humans
  96. Dominici LS, Lester S, Liao GS, Guo L, Specht M, Smith BL, Golshan M. Current surgical approach to Paget's disease. Am J Surg. 2012 Jul; 204(1):18-22. PMID: 22036205.
    Citations: 3     Fields:    Translation:Humans
  97. Barkley C, Burstein H, Smith B, Bellon J, Wong J, Gadd M, Taghian A, Winer E, Iglehart JD, Harris J, Golshan M. Can axillary node dissection be omitted in a subset of patients with low local and regional failure rates? Breast J. 2012 Jan-Feb; 18(1):23-7. PMID: 22017599.
    Citations: 3     Fields:    Translation:Humans
  98. Valero M, Dominici LS, Golshan M. Use of intraoperative digital specimen mammography to improve operative efficiency. J Clin Oncol. 2011 Sep 20; 29(27_suppl):138. PMID: 27958142.
    Citations:    
  99. Childs SK, Chen Y, Pochebit S, Golshan M, Duggan MM, Wong JS, Harris JR, Bellon JR. Surgical margins and the risk of local-regional recurrence (LRR) following mastectomy for early-stage breast cancer. J Clin Oncol. 2011 Sep 20; 29(27_suppl):95. PMID: 27957926.
    Citations:    
  100. Valero MG, Raut CP, Lotfi P, Golshan M. Atypical lipomatous tumor of the breast. J Clin Oncol. 2011 Nov 01; 29(31):e766-8. PMID: 21931026.
    Citations:    Fields:    Translation:HumansCells
  101. Dominici L, Najita J, Hughes M, Niland J, Marcom P, Wong YN, Carter B, Javid S, Edge S, Burstein H, Golshan M. Surgery of the primary tumor does not improve survival in stage IV breast cancer. Breast Cancer Res Treat. 2011 Sep; 129(2):459-65. PMID: 21713372.
    Citations: 13     Fields:    Translation:Humans
  102. Hu YY, Weeks CM, In H, Dodgion CM, Golshan M, Chun YS, Hassett MJ, Corso KA, Gu X, Lipsitz SR, Greenberg CC. Impact of neoadjuvant chemotherapy on breast reconstruction. Cancer. 2011 Jul 01; 117(13):2833-41. PMID: 21264833.
    Citations: 7     Fields:    Translation:Humans
  103. Nasrinossadat A, Ladan F, Fereshte E, Asieh O, Reza C, Akramossadat S, Golshan M. Marking non-palpable breast masses with injected methylene blue dye, an easy, safe and low cost method for developing countries and resource-limited areas. Asian Pac J Cancer Prev. 2011; 12(5):1189-92. PMID: 21875264.
    Citations: 2     Fields:    Translation:Humans
  104. Dominici L, Golshan M. Can axillary lymph node dissection be omitted in patients with breast cancer and positive sentinel nodes? Minerva Chir. 2010 Oct; 65(5):547-54. PMID: 21081866.
    Citations:    Fields:    Translation:Humans
  105. Golshan M, Garber JE, Gelman R, Tung N, Smith BL, Troyan S, Greenberg CC, Winer EP, Ryan P. Does neoadjuvant bevacizumab increase surgical complications in breast surgery? Ann Surg Oncol. 2011 Mar; 18(3):733-7. PMID: 20882415.
    Citations: 7     Fields:    Translation:Humans
  106. Bafford A, Gadd M, Gu X, Lipsitz S, Golshan M. Diminishing morbidity with the increased use of sentinel node biopsy in breast carcinoma. Am J Surg. 2010 Sep; 200(3):374-7. PMID: 20409517.
    Citations: 5     Fields:    Translation:Humans
  107. Chun YS, Verma K, Rosen H, Lipsitz SR, Breuing K, Guo L, Golshan M, Grigorian N, Eriksson E. Use of tumescent mastectomy technique as a risk factor for native breast skin flap necrosis following immediate breast reconstruction. Am J Surg. 2011 Feb; 201(2):160-5. PMID: 20409522.
    Citations: 10     Fields:    Translation:Humans
  108. Bafford, A, Gadd, M, Gu, X, Lipsitz, S, Golshan, M . Diminishing morbidity with the increased use of sentinel node biopsy in breast carcinoma. American Journal of Surgery. 2010; (epub ahead of print).
  109. Chun YS, Verma K, Rosen H, Lipsitz SR, Breuing K, Guo L, Golshan M, Grigorian N, Eriksson E. Use of tumescent mastectomy technique as a risk factor for native breast skin flap necrosis following immediate breast reconstruction. Am J Surg. 2010; (epub ahead of print).
  110. Javid S, Segara D, Lotfi P, Raza S, Golshan M. Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy. Ann Surg Oncol. 2010 Jul; 17(7):1841-6. PMID: 20143266.
    Citations: 8     Fields:    Translation:Humans
  111. Murphy CD, Golshan M. Multidisciplinary Approach in the Treatment of Metastastic Disease: Surgical Managment of Metastatic Disease. Breast Cancer. 2010; 197-201.
  112. Golshan M. Kuerer's Breast Surgical Oncology. Follow-up and complications following diagnosis and therapy. 2010; 1021-1081.
  113. Garber JE, Golshan M. Contralateral Breast Cancer in BRCA1/2 Mutation Carriers: The Story of the Other Side. Journal of Clinical Oncology. 2009; 27(35):5862-5864.
  114. Garber JE, Golshan M. Contralateral breast cancer in BRCA1/BRCA2 mutation carriers: the story of the other side. J Clin Oncol. 2009 Dec 10; 27(35):5862-4. PMID: 19858367.
    Citations: 1     Fields:    Translation:Humans
  115. Golshan M. Examination Techniques: Roles of the Physician and Patient in Evaluating Breast Disease. The Breast. 2009.
  116. Golshan M. Mastectomy. Diseases of the Breast. 2009; 501-507.
  117. Ahmadiyeh N, Stoleru MA, Raza S, Lester SC, Golshan M. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome. Ann Surg Oncol. 2009 Aug; 16(8):2264-9. PMID: 19484312.
    Citations: 12     Fields:    Translation:Humans
  118. Ryan PD, Tung NM, Isakoff SJ, Golshan M, Richardson A, Corben AD, Smith BL, Gelman R, Winer EP, Garber JE. Neoadjuvant cisplatin and bevacizumab in triple negative breast cancer (TNBC): Safety and efficacy. J Clin Oncol. 2009 May 20; 27(15_suppl):551. PMID: 27960664.
    Citations:    
  119. Ligibel JA, Partridge A, Giobbie-Hurder A, Golshan M, Emmons K, Winer EP. Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ. Ann Surg Oncol. 2009 Jan; 16(1):106-12. PMID: 18953612.
    Citations: 10     Fields:    Translation:Humans
  120. Barkley CR, Ligibel JA, Wong JS, Lipsitz S, Smith BL, Golshan M. Mucinous breast carcinoma: a large contemporary series. Am J Surg. 2008 Oct; 196(4):549-51. PMID: 18809061.
    Citations: 16     Fields:    Translation:Humans
  121. Barkley CR, Ligibel JA, Wong JS, Lipsitz S, Smith BL, Golshan M. Mucinous breast carcinoma: a large contemporary series. American J Surg. 2008; 196(4):549-551.
  122. Javid SH, Smith BL, Mayer E, Bellon J, Murphy CD, Lipsitz S, Golshan M. Tubular carcinoma of the breast: results of a large contemporary series. American J Surg. 2008; epub ahead of print.
  123. Javid SH, Smith BL, Mayer E, Bellon J, Murphy CD, Lipsitz S, Golshan M. Tubular carcinoma of the breast: results of a large contemporary series. Am J Surg. 2009 May; 197(5):674-7. PMID: 18789411.
    Citations: 4     Fields:    Translation:Humans
  124. Cady B, Nathan NR, Michaelson JS, Golshan M, Smith BL. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site. Ann Surg Oncol. 2008 Dec; 15(12):3384-95. PMID: 18726129.
    Citations: 17     Fields:    Translation:Humans
  125. Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR. Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review. J Clin Oncol. 2008 Oct 20; 26(30):4981-9. PMID: 18711171.
    Citations: 34     Fields:    Translation:Humans
  126. Bafford AC, Burstein HJ, Barkley CR, Smith BL, Lipsitz S, Iglehart JD, Winer EP, Golshan M. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat. 2009 May; 115(1):7-12. PMID: 18581232.
    Citations: 20     Fields:    Translation:Humans
  127. Partridge A, Winer JP, Golshan M, Bellon JR, Blood E, Dees EC, Sampson E, Emmons KM, Winer E. Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ. Clin Breast Cancer. 2008 Jun; 8(3):275-80. PMID: 18650159.
    Citations: 8     Fields:    Translation:Humans
  128. Steven Harms, MD, Amy Early, MD, Therese B. Bevers, MD, Armando Giuliano, MD, Mehra Golshan, MD, Ilona H. Hertz, MD, Krystyna D. Kiel, MD, Philip B. Kivitz, MD, A. Marilyn Leitch, MD, Beth A. Overmoyer, MD, Hernan I. Vargas, MD, Edibaldo Silva, MD, PhD, Kalliopi P. Siziopikou, MD, PhD, Craig D. Shriver, MD, Olufunmilayo Olopade, MD American Society of Breast Disease Consensus Committee. American Society of Breast Disease Policy Statement on The Use of Breast Magnetic Resonance Imaging. Seminars in Breast Disease. 2008; 11(2):111-112.
  129. Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, Kelada A, Rizk L, Wong JS, Bellon JR, Gadd M, Specht M, Taghian AG. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol. 2008 May 01; 26(13):2093-8. PMID: 18445838.
    Citations: 27     Fields:    Translation:Humans
  130. Golshan M. Breast Pain. Common Surgical Diseases. 2008.
  131. Bafford AC, Garber JE, Chittenden A, Golshan M. Young Breast Cancer Patients Undergoing Breast- Conserving Therapy: Role of BRCA1 and BRCA2. Methods of Cancer Diagnosis, Therapy and Prognosis. 2008; In press.
  132. Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008 Feb 20; 100(4):243-51. PMID: 18270338.
    Citations: 44     Fields:    Translation:HumansPHPublic Health
  133. Greenberg CC, Bafford AC, Golshan M. Is axillary dissection needed in node-positive breast cancer? Expert Rev Anticancer Ther. 2008 Feb; 8(2):195-8. PMID: 18279060.
    Citations: 2     Fields:    Translation:Humans
  134. Segara D, Krop IE, Garber JE, Winer E, Harris L, Bellon JR, Birdwell R, Lester S, Lipsitz S, Iglehart JD, Golshan M. Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol. 2007 Nov 01; 96(6):474-80. PMID: 17640031.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  135. Dominguez FJ, Golshan M, Black DM, Hughes KS, Gadd MA, Christian R, Lesnikoski BA, Specht M, Michaelson J, Smith BL. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ. Ann Surg Oncol. 2008 Jan; 15(1):268-73. PMID: 17891441.
    Citations: 9     Fields:    Translation:Humans
  136. Carlson JW, Birdwell RL, Gombos EC, Golshan M, Smith DN, Lester SC. MRI-directed, wire-localized breast excisions: incidence of malignancy and recommendations for pathologic evaluation. Hum Pathol. 2007 Dec; 38(12):1754-9. PMID: 17868777.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  137. Javid SH, Carlson JW, Garber JE, Birdwell RL, Lester S, Lipsitz S, Golshan M. Breast MRI wire-guided excisional biopsy: specimen size as compared to mammogram wire-guided excisional biopsy and implications for use. Ann Surg Oncol. 2007 Dec; 14(12):3352-8. PMID: 17849165.
    Citations:    Fields:    Translation:Humans
  138. Golshan M, Rusby J, Dominguez F, Smith BL. Breast conservation for male breast carcinoma. Breast. 2007 Dec; 16(6):653-6. PMID: 17606375.
    Citations: 11     Fields:    Translation:Humans
  139. Golshan M, Greenberg CG. Commentary on "Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board". American Journal of Hematology/Oncology. 2007; 6(7):13-14.
  140. Golshan M. Multidisciplinary breast cancer care: perspectives from team members at Dana-Farber Cancer Institute. American Journal of Hematology/Oncology. 2007; 6(7):18-19.
  141. Javid S, Carlson J, Garber J, Birdwell R, Lester S, Golshan M. Comparing Resection Volume: Breast MRI Wire Localized Excisional Biopsy (MRIbx) vs. Mammogram Wire Localized Excisional Biopsy (Mammobx). Annals of Surgical Oncology. 2007; 14(2):S38.
  142. Garber JE, Richrdson A, Harris LN, Miron A, Silver D, Golshan M, Ryan PD, Ganesan S, Li X, Wang ZC, Clare K, Tung NM, Iglehart JD, Winer EP. Neo-adjuvant cisplatin in "triple-negative" breast cancer. San Antonio Breast Conference. 2006; S149.
  143. Black D, Golshan M, Christian R, Nakhlis F, Dominguez F, Smith B, Lesnikoski B. Post-operative outcomes of mastectomy with breast tumescence infiltration. Proceedings of the San Antonio Breast Conference. 2006; S123.
  144. Rusby JE, Smith BL, Dominguez FJ, Golshan M. Sentinel lymph node biopsy in men with breast cancer: a report of 31 consecutive procedures and review of the literature. Clin Breast Cancer. 2006 Dec; 7(5):406-10. PMID: 17239266.
    Citations: 1     Fields:    Translation:Humans
  145. A. Katz, B. Smith, M. Golshan, A. Niemierko, W. Kobayashi, M. Gadd, M. Specht, L. Rizk, A. Kelada, and A. Taghian . Factors Associated with Involvement Of Four or More Axillary Nodes for Sentinel Lymph Node Positive Patients. Proceedings of the American Society of Therapeutic Radiology and Oncology. 2006.
  146. Golshan M, Smith BL. Prevention and Management of Lymphedema in the Patient with Breast Cancer. Journal of Supportive Oncology. 2006; 4:381-386.
  147. Golshan M, Smith B. Prevention and management of arm lymphedema in the patient with breast cancer. J Support Oncol. 2006 Sep; 4(8):381-6. PMID: 17004511.
    Citations: 10     Fields:    Translation:Humans
  148. Golshan M, Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer? Breast J. 2006 Sep-Oct; 12(5):428-30. PMID: 16958960.
    Citations: 15     Fields:    Translation:Humans
  149. Golshan M, Miron A, Nixon AJ, Garber JE, Cash EP, Iglehart JD, Harris JR, Wong JS. The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy. Am J Surg. 2006 Jul; 192(1):58-62. PMID: 16769276.
    Citations: 3     Fields:    Translation:Humans
  150. Golshan M, Lesnikoski BA, Lester S. Sentinel lymph node biopsy for occult breast cancer detected during breast reduction surgery. Am Surg. 2006 May; 72(5):397-400. PMID: 16719192.
    Citations: 2     Fields:    Translation:Humans
  151. Golshan M. Lymphedema in Breast Cancer Patients: Declining But Awareness Still Needed. The Journal of Supportive Oncology. 2006; 4(2):71.
  152. Golshan M, Witt T. Breast Cancer. Review of Surgery. 2006.
  153. Golshan M, Iglehart JD. Surgical Management of Breast Cancer Metastases Review. Oncology. 2005; 19(12):1587-88.
  154. Golshan M, Kuten A, William J, Richardson A, Modarressi A, Matulonis U. Metaplastic carcinoma of the breast with neuroglial differentiation. Breast. 2006 Aug; 15(4):545-9. PMID: 16253505.
    Citations: 3     Fields:    Translation:HumansCells
  155. Nakhlis F, Duggan M, Golshan M, Levin E. Preclinical breast MRI findings in inflammatory breast carcinoma. J Clin Oncol. 2005 Jun; 23(16_suppl):899. PMID: 27945312.
    Citations:    
  156. Golshan M. General Surgery Problem Based Learning Case for Core Surgery Clerkship (on Virtual Patient platform of MyCourses): Breast cancer. 2005.
  157. Golshan, M. Diagnostic Tools: Windows into the Body. Cure. 2005; IV(Winter).
  158. Nakhlis F, Levin E, Duggan NM, Golshan M. "Preclinical breast MRI findings in inflammatory breast carcinoma". Proceedings of the American Society of Clinical Oncology. 2005; p.559.
  159. Golshan M, Iglehart JD. Nipple Discharge. 2005.
  160. Golshan M. "Prevention and Management of Lymphedema in the Breast Cancer Patient: Separating Myth from Evidence". Journal of Supportive Oncology. 2005; 5:13.
  161. Golshan M, Iglehart JD. Breast Pain. 2005.
  162. Golshan M. General Surgery Problem Based Learning Case for Core Surgery Clerkship (on Virtual Patient platform of MyCourses): Breast Mass. 2005.
  163. Golshan M, Fung BB, Wiley E, Wolfman J, Rademaker A, Morrow M. Prediction of breast cancer size by ultrasound, mammography and core biopsy. Breast. 2004 Aug; 13(4):265-71. PMID: 15325659.
    Citations: 11     Fields:    Translation:Humans
  164. Golshan M, Miron A, Harris J, Wong J, Iglehart J. "The prevalence of BRCA 1 and BRCA 2 mutations in young women with breast cancer selecting breast conservation". Proceedings of the New England Surgical Society Meeting. 2004; 27.
  165. Golshan M, Fung BB, Wolfman J, Rademaker A, Morrow M. The effect of ipsilateral whole breast ultrasonography on the surgical management of breast carcinoma. Am J Surg. 2003 Oct; 186(4):391-6. PMID: 14553857.
    Citations:    Fields:    Translation:Humans
  166. Golshan M, Amra B, Hoghoghi MA. Is arm span an accurate measure of height to predict pulmonary function parameters? Monaldi Arch Chest Dis. 2003 Jul-Sep; 59(3):189-92. PMID: 15065313.
    Citations:    
  167. Christein JD, Kim AW, Golshan MA, Maxhimer J, Deziel DJ, Prinz RA. Central pancreatectomy for the resection of benign or low malignant potential neoplasms. World J Surg. 2003 May; 27(5):595-8. PMID: 12715230.
    Citations: 17     Fields:    Translation:Humans
  168. Golshan M, Martin WJ, Dowlatshahi K. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg. 2003 Mar; 69(3):209-11; discussion 212. PMID: 12678476.
    Citations: 18     Fields:    Translation:Humans
  169. Golshan M, Fung S, Wiley E, Wolfman J, Rademaker A, Morrow M. "How accurately do ultrasound and core biopsy predict size in breast cancer". Annals of Surgical Oncology. 2003; 10:16-17.
  170. Golshan M, Khan S. Role of Breast Epithelial Sampling Techniques in High-Risk women. Managing Breast Cancer Risk. 2003; 138-157.
  171. Golshan M, Goldfarb R, Kilbourn R. . "Nitric oxide inhibition and dobutamine augmentation of cardiac output in septic shock". Proceedings of the American Assoication for the Surgery of Trauma. 2002; 234.
  172. Kim AW, Cacciopo JR, Golshan MA, Templeton AC, Prinz RA. Pancreatic epithelial cyst in an adult treated by central pancreatectomy. J Gastrointest Surg. 2001 Nov-Dec; 5(6):634-7. PMID: 12086902.
    Citations: 4     Fields:    Translation:Humans
  173. Golshan M, Goldfarb R, Kilbourn R. "Nitric Oxide inhibition and dobutamine augmentation of cardiac output in shock". Journal of Surgical Research. 1999; 86:303.
  174. Golshan M, Lotfi P, Prinz R. Exploration for multiglandular disease in primary hyperparathyroidism. Operative Techniques in General Surgery. 1999; 1(1):85-95.
  175. Golshan MM, McHenry CR, de Vente J, Kalajyian RC, Hsu RM, Tomashefski JF. Acute suppurative thyroiditis and necrosis of the thyroid gland: a rare endocrine manifestation of acquired immunodeficiency syndrome. Surgery. 1997 May; 121(5):593-6. PMID: 9142162.
    Citations: 6     Fields:    Translation:HumansCells
  176. Pearlman E, Kazura J,Diaconu E, Bardenstein D, Golshan M, Hazlett F, Lass J. "Sclerosing keratitis induced by onchocerca volvulus antigens correlates with production of Th-2 assoicated cytokines". Invest Ophthalmol Vis Sci. 1993; 34:86.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Golshan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (315)
Explore
_
Co-Authors (104)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.